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BACKGROUND 
Reconstructed human epidermis (RHE) mimic normal human in vivo epidermis in terms of histology, 
distribution of differentiation markers, and barrier functionality (1).  
A typical transcriptional profile and the activation of signalling pathways reminiscent of atopic 
dermatitis (AD) lesional skin can be obtained in RHE upon incubation with methyl-?-cyclodextrin 
(M?CD) (2, 3), a molecule that extracts cholesterol from plasma membranes, thereby disrupting lipid 
microdomains. However, barrier function and morphology remain unaltered in those conditions, 
requiring further refinement of the model.  
 
QUESTION ADDRESSED  
 
Because of the crucial role played by Th2 immune response in AD, a mixture of interleukins linked to 
this Th2 response (IL-4, IL-13 and IL-25) was used in addition to M?CD, in an attempt to induce most 
of the epidermal AD features in RHE.  Ultimately, a valid RHE model of acute AD would allow studying 
the epidermal component of pathogenesis.  
 
EXPERIMENTAL DESIGN  
 
RHE were incubated for two hours with M?CD in order to induce cholesterol depletion (Figure S1), 
then for 48 hours with the interleukin mix and compared to control tissues, and to tissues incubated 
with either M?CD or interleukins.  
  
RESULTS 
 
When allowed to recover in fresh culture medium after incubation with M?CD for 2 hours, RHE 
revealed no obvious histological alteration when compared with untreated RHE (Figure 1a). 
Conversely, RHE treated with IL-4, IL-13 and IL-25 for 48 hours displayed intercellular space widening 
similar to spongiosis (already reported for IL-4 and IL-13 (4-6)) and hypogranulosis, two histological 
hallmarks of lesional AD skin (Figure S2). These morphological alterations were enhanced when 
keratinocytes were challenged by M?CD before being incubated with the three interleukins (Figure 
1a).  
 
Barrier function, weakened in AD, was studied using two assays: measurement of trans-epithelial 
electrical resistance (TEER) and assessment of permeability to the fluorescent dye lucifer yellow (LY) 
through the RHE. A significant decrease in TEER was observed in RHE incubated with the interleukins, 
and worsened upon membrane cholesterol depletion (Figure 1b). Accordingly, permeability of RHE 
towards LY was significantly increased after combined treatments, whereas cholesterol depletion 
alone or incubation with interleukins only were insufficient to elicit an effect (Figure 1c).  
Then, expression of atopic dermatitis markers was investigated. Gene expression of filaggrin (FLG) 
and loricrin (LOR), epidermal differentiation genes usually downregulated in lesional AD, was 
analyzed through RT-qPCR (Figure 2a). FLG and LOR exhibited reduced mRNA levels in RHE incubated 
with IL-4, -13 and -25, as already reported in the literature regardless of the different concentrations 
and timings used (5). This decrease was exacerbated and became significant when keratinocytes 
were challenged by cholesterol depletion before incubation with the interleukins. Simultaneously, 
relative expression levels of carbonic anhydrase II (CA2) and neural epidermal growth factor-like 2 
(NELL2), two genes upregulated in AD (7), were significantly enhanced in RHE in response to 
incubation with interleukins (Figure 2a). 
Immunohistological analysis confirmed decreased expression of LOR and increased expression of CA2 
in AD lesions (Figure S3a). Similar changes were observed in RHE treated with interleukins and 
became even more evident in tissues previously treated with M?CD (Figure S3b).  
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Expression levels for hyaluronan synthase 3 (HAS3) were found elevated in RHE exposed to 
interleukins and further increased after combined treatments (Figure 2a), in agreement with the 
upregulation observed in AD (4, 8). Though, no significant changes were found with respect to HAS1 
expression levels (data not shown), unlike data collected from AD lesions (8).  
Fluorescent detection of hyaluronic acid (HA) revealed increased staining of intercellular spaces 
between keratinocytes in AD lesions (Figure S4a). HA was also more strongly detected in RHE 
incubated with interleukins, particularly after previous challenging by M?CD (Figure S4b). 
Accordingly, increased HA concentrations were measured in culture medium of treated RHE (Figure 
S4c). 
 
TSLP is a cytokine, upregulated in AD, which contributes to Th2 immune response activation, 
promotes itch in skin and the ‘atopic march’ in general (9). However, despite significant induction in 
response to two hours of M?CD (Figure S1c), mRNA expression levels for TSLP were no longer above 
baseline 48 hours later (Figure 2a). However, in the meantime, over the 6 hours period following 
cholesterol depletion (Figure 2b), data illustrate that interleukins and M?CD concur to significantly 
enhance TSLP expression in challenged RHE. 
 
CONCLUSIONS 
This study illustrates that challenging RHE through cholesterol depletion, or by incubation with IL-4, 
IL-13 and IL-25, results in multiple epidermal alterations. But interestingly, a combination of those 
two treatments has additive effects, allowing mimicking an AD-like epidermal phenotype in vitro in 
the absence of immune cells. Indeed, morphological alterations such as tissue spongiosis and 
hypogranulosis, alterations in mRNA expression levels and histological localizations of typical AD and 
differentiation markers, modulations of epidermal HA synthesis, and epidermal barrier weakening 
represent hallmarks of AD epidermis.  
In vivo, such alterations become responsible for activation of the immune system because they 
promote penetration of pathogens or allergens, thereby creating some vicious circle likely 
responsible for AD lesions development (Figure 2c). 
Most probably, challenging of keratinocytes by M?CD models alterations in cell signalling through 
disorganization of specific lipid microdomains in this cell type (3). Interestingly, gene expression 
levels for IL-13R?2, IL-13R?1, IL-4R? and IL-17RA (subunit of IL-25 receptor) were upregulated in 
keratinocytes incubated with M?CD (3). This indicates that cholesterol-containing lipid microdomains 
could regulate signalling through these receptors and could therefore explain the additive effects 
observed in this study.  
In conclusion, this study confirms that membrane cholesterol depletion in keratinocytes concurs with 
Th2-related cytokines to elicit an AD-like phenotype. The present model could be used in order to 
study other features encountered in AD epidermis, but also evaluate compounds intending to 
relieve, prevent AD lesions or restore keratinocyte functions. 
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FIGURE LEGENDS  
Figure 1. Morphology and barrier efficiency in treated RHE.  
 
(a) Histological sections of RHE treated for 2 hours with M?CD followed by 48 hours of recovery 
(M?CD 2h + recovery 48h) or treated for 48 hours with IL-4, IL-13 and IL-25 (IL 48h), or a combination 
of both treatments (M?CD 2h + IL 48h), compared to non-treated RHE (Ctrl 48h). Images are 
representative of three independent cultures. Scale bar=50µm. 
Analysis of barrier function, by (b) trans-epidermal electrical resistance (TEER) or (c) fluorescence 
quantification of lucifer yellow permeation in the culture medium, of RHE treated for 2 hours with 
M?CD (M?CD2h), followed or not by 48h incubation with interleukins 4, 13 and 25 (IL 48h). Data 
represent measurements performed on three independent cultures (error bars = SEM, one-way RM 
ANOVA and *P<0.05, **P<0.01). 
  
 
Figure 2. Transcriptional regulation of atopic dermatitis markers in treated RHE and hypothetical 
simplified model for AD-like pathogenesis. 
 
(a) RT-qPCR analysis of the expression of filaggrin (FLG), loricrin (LOR), thymic stromal lymphopoietin 
(TSLP), carbonic anhydrase II (CA2), neural epidermal growth factor-like 2 (NELL2) and hyaluronan 
synthase 3 (HAS3) were performed on total RNA extracted from RHE treated with M?CD (M?CD2h) 
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and/or interleukins 4, 13 and 25 (IL48h). Levels of mRNA expression in control conditions were 
arbitrarily fixed at 1. Error bars represent 95% confidence intervals (n=3 independent cultures, one-
way RM ANOVA, *P<0.05, **P<0.01, ***P <0.001). 
(b) TSLP mRNA expression was quantified by RT-qPCR in RHE incubated for 2 hours with MβCD, 
followed or not by incubation with IL-4, IL-13 and IL-25 for 2h, 4h or 6h. Values are expressed relative 
to control condition (no M?CD + no IL). Error bars represent 95% confidence intervals (n=3 
independent cultures, two-way RM ANOVA, *P<0.05, **P<0.01, ***P <0.001) 
(d) Plasma membrane cholesterol depletion with MβCD in RHE challenges keratinocytes which in 
turn produce TSLP, a Th2 response-activating cytokine. Addition of Th2-related interleukins in the 
culture medium intends to mimic consequences of the activation of immune cells in vivo. Response 
of challenged RHE includes morphological alterations as well as weakening of the epidermal barrier. 
In vivo, activation of the immune system resulting from altered barrier function, would maintain the 
vicious circle observed in AD. 
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SUPPLEMENTARY FIGURES 
 
 
 
 
Figure S1 Effect of incubation with MbCD for 2 hours on RHE analysed at day 11 of tissue reconstruction.  
 
(a) Localization of cholesterol. Frozen sections of RHE were stained with filipin and observed under a 
fluorescent microscope using UV wavelength as excitation light (DAPI filters). RHE were left untreated (MbCD -) 
or treated with 7.5mM MbCD for two hours (MbCD +) followed by different recovery periods (0h, 2h, 4h, 6h 
and 24h). White dotted lines delineate the polycarbonate filter (scale bar = 50 μm). (b) Cholesterol was 
quantified in RHE left untreated (ctrl 0h and ctrl 24h) or in RHE incubated with 7.5mM MbCD for two hours 
before different recovery periods (0h, 2h, 4h, 6h and 24h). (c) RT-qPCR analysis of TSLP expression in RHE, 
incubated or not with MbCD during 1h or 2h. The values are relative to the control conditions (Ctrl 1h and Ctrl 
2h). (d) RT-qPCR analysis of heparin-binding EGF-like growth factor (HB-EGF), IL-8 and plasminogen activator 
urokinase receptor (PLAUR) mRNA expression levels in RHE during the recovery period after 2 hours of MbCD 
treatment. Error bars represent 95% confidence intervals (n=3, two-way repeated-measures analysis of 
variance, **P<0.01).  
  
Figure S2. Morphology of healthy and lesional AD skin biopsies.  
 
Histological analysis sections of healthy and lesional AD skin biopsies. After fixation, biopsies were embedded 
in paraffin before staining with haematoxylin and eosin. Scale bars=50µm. 
  
 Figure S3. Labeling of atopic dermatitis-associated markers.  
 
Immunoperoxidase-labelling of carbonic anhydrase 2 (CA2) and hematoxylin counterstaining as well as 
immunofluorescence labelling of loricrin (LOR) in green and nuclei in blue (Hoechst 33258).  
(a) Healthy, non-lesional and lesional atopic dermatitis skin sections. (b) RHE treated for 2 hours with MβCD 
followed (MβCD 2h + IL 48h) or not (MβCD 2h + recovery 48 h) by 48h of incubation in the presence of IL-4, -13 
and -25 (IL 48h) were processed for histology and analyzed for CA2 and LOR. Results shown are representative 
of three independent experiments. Scale bars= 50µm.  
  
Figure S4. Hyaluronic acid (HA) staining and concentration in the culture medium. 
 
(a) Healthy, non-lesional and lesional atopic dermatitis skin biopsies or (b) reconstructed human epidermis 
(RHE) were processed for histology and immunostaining of hyaluronic acid (HA) was realised using a 
biotinylated hyaluronic acid (HA)-binding protein staining (green). Hoechst 33258 (blue) was used for nuclei 
staining. RHE were treated with a combination of 2 hours of treatment with MbCD followed by 48h of 
interleukins 4, 13 and 25 treatment at the 11th day of reconstruction (MβCD 2h + IL 48h). These RHE were 
compared to RHE treated with MβCD during 2 hours followed by incubation in fresh culture medium (MβCD 2h 
+ recovery 48 h) or treated during 48 hours with interleukins only (IL 48h) as well as untreated RHE (ctrl 48h). 
Results shown are representative of three independent experiments. (c) Culture media of the last 48 hours of 
culture were harvested and released HA concentrations were measured. Data are shown as means ± SD (n=3, 
one-way repeated-measures analysis of variance, *P<0.05).   
MATERIALS AND METHODS 
 
Skin biopsies and reconstruction of human epidermis 
 
Healthy adult human skin samples were obtained from abdominoplasties (kindly provided by Dr. B. 
Bienfait, Clinique St. Luc, Namur-Bouge, Belgium) and keratinocytes were cultured as described (De 
Vuyst et al., 2014; Frankart et al., 2012; Poumay et al., 2004). After 11 days of culture, RHE were 
treated for 2 hours with 7.5 mM MβCD (Sigma-Aldrich, Diegem, Belgium). A treatment for two hours 
with MβCD was selected because it induced a significant increase in expression of thymic stromal 
lymphopoïetin (TSLP), a well-known actor in AD (Figure S1c), without alteration of RHE viability (data 
not shown). Transient extraction of cholesterol as well as activation of known target genes by MβCD 
was evaluated (Figure S1) confirming previous data (De Vuyst et al., 2015). 
After MβCD treatment, RHE were rinsed before culture for the next 48 hours in the presence of 
respectively 50 ng/ml IL-4, 50 ng/ml IL-13, and 20 ng/ml IL-25 (Peprotech, London, UK). The choice 
for IL-4 and IL-13 was first based on experiments already published showing elevated expression 
levels of these cytokines in lesional AD skin (Howell et al., 2009; Tazawa et al., 2004). Further 
interesting, these interleukins could induce a significant decrease of filaggrin expression in primary 
human keratinocytes (Howell et al., 2009; Pellerin et al., 2013). Furthermore, other in vitro models of 
AD also used cytokine mix and notably IL-4 and IL-13 (Bernard et al., 2012; Danso et al., 2014; 
Kamsteeg et al., 2011). IL-25 was added for different reasons. First, because increased levels of this 
cytokine and its receptor were detected in the epidermis of AD patients (Aktar et al., 2015; Hvid et 
al., 2011; Wang et al., 2007). Besides this reason, IL-25 would play a dual role in AD, promoting type 
2 cell immunity (Salimi et al., 2013; Wang et al., 2007), but also inhibiting filaggrin (FLG) expression in 
keratinocytes (Hvid et al., 2011; Pellerin et al., 2013), thereby affecting skin barrier in AD patients. 
Therefore, acting both on immune and epidermal cells, IL-25 may provide, in collaboration with TSLP, 
some explanation for the link observed between inflammation and barrier disruption in AD lesions 
(Deleuran et al., 2012). Furthermore, in the skin of AD patients, expression of IL-25 and its receptor 
was increased after exposure to allergens (Corrigan et al., 2011). For all these reasons, we thought it 
could be of interest as a potentially therapeutic target and could therefore be added in our model 
contribute to the development of the pathogenesis, and partly explain the vicious circle observed in 
AD.  
 
AD biopsies were collected from lesional or surrounding non-lesional skin of patients suffering from 
longstanding disease.  
 
This study was conducted according to the Declaration of Helsinki Principles and approved by the 
Ethics Committees. 
 
Morphological analysis and labelling  
 
RHE or biopsies were embedded in paraffin. Sections were stained with haematoxylin-eosin-
(saffron). Images were obtained by light microscopy using Olympus BX63 microscope. 
For CA2 immunodetection, antigen retrieval was performed by heat-induction. Anti-rabbit CA2 from 
Sigma-Aldrich (Diegem, Belgium) was diluted 1:500, anti-rabbit LOR from Abcam (Cambridge, UK) 
1:100 and biotinylated HA-binding complex (generously provided by Prof. M. Tammi) was diluted 
1:50. Tissue samples were incubated for one hour with anti-rabbit HRP secondary antibody 
(Vectastain ABC kit, Vector Laboratories, Peterborough, UK) diluted 1:100 for the CAII staining or 
with Alexa 488 conjugated anti-rabbit IgG (Life technologies, New York, USA) also diluted 1:100 for 
the LOR staining or with fluorescein-labelled streptavidin (Vector Laboratories, Peterborough, UK) for 
the HA labelling. 
 
TEER measurements and permeability to lucifer yellow 
 
TEER measurements were performed using Millicel electrical resistance system from Merck-Millipore 
(Overijse, Belgium). The fluorescent dye lucifer yellow was obtained from Sigma-Aldrich (Diegem, 
Belgium) and applied topically at a concentration of 1 mM in PBS on the RHE for 6 hours at 37°C. 
Afterwards, the medium was collected for fluorescence measurement (lex: 485nm; lem: 535nm).  
 
Analysis of mRNA expression by RT-qPCR 
 
Total RNA was extracted from RHE using RNeasy kit (Qiagen, Hilden, Germany), reverse transcribed 
using the Super Script II RNase H-reverse transcriptase kit (Invitrogen, Merelbeke, Belgium) and 
amplified with the FastStart Universal SYBR Green Master (Roche, Basel, Switzerland) in the Light 
Cycler® 96 Real-Time PCR system (Roche, Diagnostics, Mannheim, Germany). Results were 
normalized to the RPLP0 reference gene (Minner and Poumay, 2009; Mound et al., 2015). Primers 
(Eurogentec, Liège, Belgium) were used at a concentration of 300 nM. Sequences are available in 
table S1. Data were analyzed using the ΔΔCq quantitative method and 95% confidence intervals were 
calculated after one-way RM ANOVA followed by Tukey tests or two-way RM ANOVA followed by 
Bonferroni correction using SigmaStat 3.0. 
 
TABLE S1: Oligonucleotides used to perform the RT-qPCR 
 Forward (5’ – 3’) Reverse (5’ – 3’) 
RPLP0 ATCAACGGGTACAAACGAGTC CAGATGGATCAGCCAAGAAGG 
FLG GGGCACTGAAAGGCAAAAAG CACCATAATCATAATCTGCACTACCA 
LOR TCATGATGCTACCCGAGGTTTG CAGAACTAGATGCAGCCGGAGA 
HAS3 GCCCTCGGCGATTCG TGGATCCAGCACAGTGTCAGA 
CAII AACAATGGTCATGCTTTCAACG TGTCCATCAAGTGAACCCCAG 
NELL2 TAAGGGTATAATGCAAGATGTCCAATT AGATCTGGGCACTGAGCAATAAA 
TSLP CGCGTCGCTCGCCAAAGAAA TGAAGCGACGCCACAATCCTTG 
HAS1 CCTCACCAACCGCATGCT GGACGAGGGCGTCTCTGA 
HB-EGF TGGCCCTCCACTCCTCATC GGGTCACAGAACCATCCTAGC 
 
Filipin staining 
 
Epidermis were embedded in OCT (Sakura Finetek, Alphen aan den Rijn, The Netherlands) and 
cryopreserved at -80°C. Frozen sections of RHE were realised and fixed for 30 min with 4% 
paraformaldehyde at room temperature. After a washing step in PBS, sections were incubated with 
50 µg/ml of filipin from Sigma-Aldrich (Diegem, Belgium) for 30 min at room temperature. After a 
washing step, sections were mounted using Mowiol (Molecular Probes, Ghent, Belgium) and filipin 
was visualised by epifluorescence using Olympus AX70 microscope with a UV filter. Pictures were 
taken using uniform conditions (quickest exposure times to avoid the rapid bleaching of filipin). 
 
Cholesterol assay 
 
Cellular cholesterol was extracted and purified from RHE by a procedure derived from the protocol of 
Selvais et al (Selvais et al., 2011). After lysis of RHE in chloroform, washing steps were realised using 
successively methanol, NaCl and CaCl2/methanol. After centrifugation, the organic phase was 
collected, Triton X-100/acetone was added and samples were evaporated before being solubilised in 
demineralised water. Cholesterol was assayed using the Amplex Red Cholesterol Assay kit from 
Molecular probes (Ghent, Belgium) according to the manufacturer’s protocol. 
 
HA quantification  
 
HA was quantified in culture media using Hyaluronan DuoSet kit (R&D systems, Abingdon, UK).  
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